Related Experiment Video
Updated: Jul 17, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Current practice when treating lung cancer in Australasia.
1Department of Radiation Oncology, South Western Sydney Area Cancer Services, Sydney, New South Wales, Australia. lois.holloway@swsahs.nsw.gov.au
Australasian Radiology
|January 16, 2007
Summary
A survey of Australian and New Zealand radiation oncology departments revealed significant variation in radiotherapy techniques for lung cancer treatment. Prescription doses and fractionation showed the widest range of practices across facilities.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- A multidisciplinary meeting focused on lung cancer radiotherapy was planned.
- A survey was conducted prior to the meeting to assess current practices.
Purpose of the Study:
- To evaluate the current use of radiotherapy for lung cancer treatment across Australia and New Zealand.
- To identify variations in treatment planning, delivery, and prescription doses.
Main Methods:
- A survey was distributed to all radiation oncology departments in Australia and New Zealand.
- The survey collected data on planning techniques, delivery set-up, and prescription doses.
- Data included information for non-small-cell lung cancer, small-cell lung cancer, and palliative/radical treatments.
Main Results:
- Significant variability was observed in radiotherapy techniques employed across different departments.
- Prescription doses and fractionation schedules demonstrated particularly wide ranges in practice.
- Variations were noted for both radical and palliative lung cancer treatments.
Conclusions:
- Current radiotherapy practices for lung cancer in Australia and New Zealand exhibit considerable heterogeneity.
- Further standardization or evidence-based guideline development may be warranted to reduce practice variation.
